Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.